Human leukocyte antigen (HLA) and single nucleotide polymorphisms (SNPs) tumor necrosis factor (TNF)-alpha -238 and -308 as genetic markers of susceptibility to psoriasis and severity of the disease in a long-term follow-up Brazilian study

International Journal of Dermatology

Volumn 49, Issue 10, 2010, Pages 1133-1140

  Magalhães, Renata Ferreira ^a,b   Biral, Ana Cristina ^a   Pancoto, João Alexandre Trés ^c   Donadi, Eduardo Antonio ^c   Mendes Júnior, Celso Texeira ^c   Magna, Luís Antonio ^a   Kraemer, Maria Helena ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b Department of Medical Clinic ^*  (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; GENE FREQUENCY; GENETIC MARKER; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PSORIASIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; BRAZIL; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HLA ANTIGENS; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PSORIASIS; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 77957114873     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2010.04465.x     Document Type: Article

References (43)

1. Farber EM, Nall ML. The natural history of psoriasis in 5,600 patients. Dermatologica 1974, 148:1-18.
2. Bos JD, De Rie MA. The pathogenesis of psoriasis: immunological facts and speculations. Immunol Today 1999, 20:40-61.
3. Bowcock AM, Cookson WO. The genetics of psoriasis, psoriatic arthritis and atopic dermatitis. Hum Mol Genet 2004, 13:R43-R55.
4. Reich K, Hüffmeier U, König IR. Association of psoriatic arthritis with the promoter polymorphism TNF -857 independent of the PSORS1 risk allele. Arthritis Rheum 2007, 56:2056-2064.
5. Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 1985, 13:450-456.
6. Magalhaes RF, Biral AC, Kraemer MH. Psoriasis in childhood with total remission x chronic disease: clinical application of HLA class I markers. J Dermatol Sci 2007, 46:77-78.
7. Biral AC, Magalhaes RF, Wastowski IJ. Association of HLA-A, -B, -C genes and TNF microsatellite polymorphism with psoriasis vulgaris: a study of genetic risk in Brazilian patients. Eur J Dermatol 2006, 16:523-529.
8. Cardoso CB, Uthida-Tanaka AM, Magalhães RF. Association between psoriasis vulgaris and MHC-DRB, -DQB genes as a contribution to disease diagnosis. Eur J Dermatol 2005, 15:159-163.
9. Balendran N, Clough RL, Arguello JR. Characterization of the major susceptibility region for psoriasis at chromosome 6p21.3. J Invest Dermatol 1999, 113:322-328.
10. Uyemura K, Yamamura M, Fivenson DF. The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J Invest Dermatol 1993, 101:701-705.
11. D'Alfonso S, Richiardi PM. A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics 1994, 39:150-154.
12. Höhler T, Kruger A, Schneider PM. A TNF-alpha promoter polymorphism is associated with juvenile onset psoriasis and psoriatic arthritis. J Invest Dermatol 1997, 109:562-565.
13. Nishibu A, Oyama N, Nakamura K, Kaneko F. Lack of association of TNF-238A and -308A in Japanese patients with psoriasis vulgaris, psoriatic arthritis and generalized pustular psoriasis. J Dermatol Sci 2002, 29:181-184.
14. Chang YT, Tsai SF, Lee DD. A study of candidate genes for psoriasis near HLA-C in Chinese patients with psoriasis. Br J Dermatol 2003, 148:418-423.
15. Van Belle G, Fisher LD, Heagerty PJ, Lumley TS. Biostatistics: A Methodology for the Health Sciences 2004, 2nd edn, ISBN: 978-0-471-03185-7, Wiley, New Jersey, Philadelphia, USA
16. Magalhaes RF, Velho PE, Machado de Moraes A. Linear psoriasis in Brazilian children and HLA haplotypes. J Eur Acad Dermatol Venereol 2007, 21:1439-1440.
17. Miller AS, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA for human nucleated cells. Nuclei Acids Res 1988, 16:1215.
18. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2h: na alternative to serological DR typing in clinical practice including donor recipient matching in cadaveric transplantation. Tissue Antigens 1997, 39:225-235.
19. Marsh HP, Haldar NA, Bunce M. Polymorphisms in tumour necrosis factor (TNF) are associated with risk of bladder cancer and grade of tumour at presentation. Br J Cancer 2003, 89:1096-1101.
20. Tuglular S, Berthoux P, Berthoux F. Polymorphisms of the tumour necrosis factor alpha gene at position -308 and TNFd microsatellite in primary IgA nephropathy. Nephrol Dial Transplant 2003, 18:724-731.
21. Sanguinetti CJ, Neto ED, Simpson AJG. Rapid silver staining and recovery of PCR products separated on polyacrylamide gels. BioTechniques 1994, 17:915-919.
22. Excoffier L, Laval G, Schneider S. Arlequin ver. 3.0. An integrated software package for population genetics data analysis. Evolutionary Bioinformatics Onlin 2005, 1:47-50.
23. Excoffier L, Laval G, Balding D. Gametic phase estimation over large genomic regions using an adaptive window approach. Hum Genomics 2003, 1:7-19.
24. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001, 68:978-989.
25. Gupta MA, Gupta AK. Age and gender differences in the impact of psoriasis on quality of life. Int J Dermatol 1995, 34:700-703.
26. Sonkar GK, Usha, Singh S. Is HLA-B27 a useful test in the diagnosis of juvenile spondyloarthropathies? Singapore Med J 2008, 49:795-799.
27. Bonfiglioli R, Conde RA, Sampaio-Barros PD. Frequency of HLA-B27 alleles in Brazilian patients with psoriatic arthritis. Clin Rheumatol 2008, 27:709-712.
28. Westendorp RG, Langermans JA, Huizinga TW. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997, 349:170-173.
29. Reich K, Westphal G, Schulz T. Combined analysis of polymorphisms of the tumor necrosis factor-alpha and interleukin-10 promoter regions and polymorphic xenobiotic metabolizing enzymes in psoriasis. J Invest Dermatol 1999, 113:214-220.
30. Rahman P, Siannis F, Butt C. TNF alpha polymorphisms and risk of psoriatic arthritis. Ann Rheum Dis 2006, 65:919-923.
31. Hounie AG, Cappi C, Cordeiro Q. TNF-alpha polymorphisms are associated with obsessive compulsive disorder. Neurosci Lett 2008, 442:86-90.
32. Drigo SA, Cunha-Neto E, Ianni B. TNF gene polymorphisms are associated with reduced survival in severe Chagas' disease cardiomyopathy patients. Microbes Infect 2006, 8:598-603.
33. Santos AR, Suffys PN, Vanderborght PR. Role of tumor necrosis factor-alpha and interleukin-10 promoter gene polymorphisms in leprosy. J Infect Dis Epub 2002, 186:1687-1691.
34. Shaw MA, Donaldson IJ, Collins A. Association and linkage of leprosy phenotypes with HLA class II and tumour necrosis factor genes. Genes Immun 2001, 2:196-204.
35. Maria de Freitas N, Imbronito AV, Neves AC. Analysis of IL-1A(-889) and TNFA(-308) gene polymorphism in Brazilian patients with generalized aggressive periodontitis. Eur Cytokine Netw Epub 2007, 18:142-147.
36. Trevilatto PC, Tramontina VA, Machado MA. Clinical, genetic and microbiological findings in a Brazilian family with aggressive periodontitis. J Clin Periodontol 2002, 29:233-239.
37. Roxo VM, Pereira NF, Pavoni DP. Polymorphisms within the tumor necrosis factor and lymphotoxin-alpha genes and endemic pemphigus foliaceus-are there any associations? Tissue Antigens 2003, 62:394-400.
38. Reich K, Garbe C, Blaschke V. Response of psoriasis to interleukin-10 is associated with suppression of cutaneous type 1 inflammation, downregulation of the epidermal interleukin-8/CXCR2 pathway and normalization of keratinocyte maturation. J Invest Dermatol 2001, 116:319-329.
39. Nedoszytko B, Szczerkowska-Dobosz A, Zabłotna M. Associations of promoter region polymorphisms in the tumour necrosis factor-alpha gene and early-onset psoriasis vulgaris in a northern Polish population. Br J Dermatol Epub 2007, 157:165-167.
40. Li C, Wang G, Gao Y. TNF-alpha gene promoter -238G>A and -308G>A polymorphisms alter risk of psoriasis vulgaris: a metanalysis. J Invest Dermatol 2007, 127:1886-1892.
41. Seitz M, Wirthmüller U, Möller B, Villiger PM. The -308 tumour necrosis factor-alpha gene polymorphism predicts therapeutic response to TNFalpha-blockers in rheumatoid arthritis and spondyloarthritis patients. Rheumatology 2007, 46:93-96.
42. de Vlam K, Gotlieb AB, Fitzgerald O. Biological biomarkers in psoriatic disease. A review. J Rheumatol 2008, 35:1443-1448.
43. Marrero AR, Leite FPN, Carvalho BA. Heterogeneity of the genome ancestry of individuals classified as white in the state of Rio Grande do Sul, Brazil. Am J Hum Biol 2005, 17:496-506.